Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DNTH

Dianthus Therapeutics Inc

May 29 • 04:00PM ET

93.01

+2.15 2.37 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KRYS RYTM BMRN INCY VKTX ALNY AXSM MDGL KROS NBIX

| Held by: VTI IWM XBI VXF IWN SCHA VTWO VHT IWC AVSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.14	Insider Own	9.51%	Shs Outstand	54.58M	Perf Week	3.77%
Market Cap	5.08B	Forward P/E	-	EPS next Y	-4.45	Insider Trans	-6.67%	Shs Float	49.47M	Perf Month	11.39%
Enterprise Value	3.97B	PEG	-	EPS next Q	-0.85	Inst Own	109.40%	Short Float	13.00%	Perf Quarter	68.53%
Income	-173.66M	P/S	3794.41	EPS this Y	12.35%	Inst Trans	39.03%	Short Ratio	6.94	Perf Half Y	110.95%
Sales	1.34M	P/B	4.23	EPS next Y	-20.79%	ROA	-21.77%	Short Interest	6.43M	Perf YTD	125.70%
Book/sh	22.01	P/C	4.58	EPS next 5Y	-5.52%	ROE	-22.70%	52W High	96.50 -3.62%	Perf Year	421.06%
Cash/sh	20.33	P/FCF	-	EPS past 3/5Y	49.46% 31.21%	ROIC	-14.44%	52W Low	16.64 459.12%	Perf 3Y	808.30%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-31.80% -	Gross Margin	72.23%	Volatility	5.22% 5.62%	Perf 5Y	-52.93%
Dividend TTM	-	EV/Sales	2966.13	EPS Y/Y TTM	-43.40%	Oper. Margin	-14318.04%	ATR (14)	4.59	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	29.25	Sales Y/Y TTM	-79.52%	Profit Margin	-12998.50%	RSI (14)	62.61	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	29.25	EPS Q/Q	-3.10%	SMA20	6.20%	Beta	1.18	Target Price	126.15
Payout	-	Debt/Eq	0.00	Sales Q/Q	-60.19%	SMA50	7.04%	Rel Volume	1.34	Prev Close	90.86
Employees	92	LT Debt/Eq	0.00	Earnings	May 05 AMC	SMA200	74.40%	Avg Volume	926.47K	Price	93.01
IPO	Jun 21, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.70% 14.72%	Trades		Volume	1,243,318	Change	2.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)